Row
M
MEDPAI Stock Diagnostic Report
Medpace CEO August Troendle sells $1.59 million in stock
Medface CEO's news of selling self-owned stock worth $1.59 million may negatively impact investment sentiment.
View Source Article ↗
AI CATALYST SCORE35 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
MEDP Analysis History (Last 30 Days)